Activating the NLRP3 inflammasome can release inflammatory factors, including IL-1β and IL-18, which induce the EMT process, thereby elevating the invasiveness and metastatic capabilities of CRC 39. The gene discussed is NLRP3; the disease is colorectal carcinoma.